All Stories

  1. Fractional flow reserve derived from coronary CT angiography: Variation of repeated analyses

    Article • Journal of Cardiovascular Computed Tomography, July 2014, Elsevier

    Professor Jens Flensted Lassen

  2. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial

    Article • The Lancet, June 2014, Elsevier

    Professor Jens Flensted Lassen

  3. Randomised comparison of manual compression and FemoSealª vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study

    Article • EuroIntervention, June 2014, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  4. Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

    Article • EuroIntervention, June 2014, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  5. Mechanical chest compressions improve quality of CPR in out-of-hospital cardiac arrest

    Article • Resuscitation, May 2014, Elsevier

    Professor Jens Flensted Lassen

  6. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for Life (SFL) groups

    Article • EuroIntervention, May 2014, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  7. REPRODUCIBILITY OF INVASIVELY MEASURED AND NON-INVASIVELY COMPUTED FRACTIONAL FLOW RESERVE

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Jens Flensted Lassen

  8. VERY LATE STENT THROMBOSIS AFTER REVASCULARIZATION WITH EVEROLIMUS- AND SIROLIMUS-ELUTING STENTS FROM THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Jens Flensted Lassen

  9. LONG-TERM CLINICAL OUTCOMES OF EVEROLIMUS-ELUTING STENTS VERSUS SIROLIMUS-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: SORT OUT IV 4-YEAR

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Jens Flensted Lassen

  10. Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Jens Flensted Lassen

  11. Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents

    Article • Scandinavian Cardiovascular Journal, February 2014, Taylor & Francis

    Professor Jens Flensted Lassen, Kari Saunamaki

  12. Long‐term outcome following percutaneous coronary intervention with drug‐eluting stents compared with bare‐metal stents in saphenous vein graft lesions: From Western Denmark heart registry

    Article • Catheterization and Cardiovascular Interventions, December 2013, Wiley

    Professor Jens Flensted Lassen

  13. Quantitative Point-of-Care Troponin T Measurement for Diagnosis and Prognosis in Patients With a Suspected Acute Myocardial Infarction

    Article • The American Journal of Cardiology, November 2013, Elsevier

    Professor Jens Flensted Lassen

  14. Clinical Outcome After Crush Versus Culotte Stenting of Coronary Artery Bifurcation Lesions

    Article • JACC Cardiovascular Interventions, November 2013, Elsevier

    Professor Jens Flensted Lassen

  15. TCT-12 Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  16. TCT-630 Vascular Response to Biolimus-eluting and Sirolimus-Eluting Stents in Patients with ST-segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  17. TCT-665 Co-registration of Optical Coherence Tomography and X-ray Angiography in Percutaneous Coronary Intervention. The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Fusion Study

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  18. TCT-214 Five-year prognostic impact of distal embolization during primary percutaneous coronary intervention in ST elevation myocardial infarction patients treated with or without distal protection

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  19. TCT-194 5-Year Outcome Of Zotarolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  20. TCT-598 Mechanisms of Incomplete Stent Apposition After Implantation of Drug-eluting Stents in patients with ST-segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  21. TCT-26 Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting. Three Year Clinical Outcome In The Nordic-Baltic Bifurcation St...

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Jens Flensted Lassen

  22. Intimal hyperplasia and vascular remodeling after everolimus‐eluting and sirolimus‐eluting stent implantation in diabetic patients: The randomized diabetes and drug‐eluting stent (DiabeDES) IV intravascular ultrasound trial

    Article • Catheterization and Cardiovascular Interventions, September 2013, Wiley

    Professor Jens Flensted Lassen

  23. Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology

    Article • Clinical Epidemiology, September 2013, Taylor & Francis

    Professor Jens Flensted Lassen, Mr Morten Madsen, Michael Maeng

  24. Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study

    Article • Journal of Cardiovascular Computed Tomography, September 2013, Elsevier

    Professor Jens Flensted Lassen

  25. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS)

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  26. Three‐dimensional multidetector computed tomography versus conventional 2‐dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation

    Article • Catheterization and Cardiovascular Interventions, July 2013, Wiley

    Professor Jens Flensted Lassen

  27. Acquired peri-stent evaginations in a second generation durable polymer drug eluting stent

    Article • Cardiovascular Revascularization Medicine, July 2013, Elsevier

    Professor Jens Flensted Lassen

  28. Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

    Article • Journal of the American College of Cardiology, July 2013, Elsevier

    Professor Jens Flensted Lassen

  29. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

    Article • JACC Cardiovascular Interventions, June 2013, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  30. Consensus from the 7th European Bifurcation Club meeting

    Article • EuroIntervention, May 2013, Europa Digital & Publishing

    Professor Manuel Pan, Professor Jens Flensted Lassen

  31. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in ...

    Article • American Heart Journal, April 2013, Elsevier

    Professor Jens Flensted Lassen, Professor gilles montalescot

  32. VERY LATE STENT THROMBOSIS AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS–ELUTING STENTS: FROM THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Jens Flensted Lassen

  33. HYBRID CORONARY REVASCULARIZATION COMBINING OFF–PUMP LEFT INTERNAL MAMMARY GRAFTING AND PCI

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Jens Flensted Lassen

  34. PREVENTION OF CONTRAST–INDUCED NEPHROPATHY IN PATIENTS WITH RENAL INSUFFICIENCY WITH STEMI

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Jens Flensted Lassen

  35. LONG–TERM OUTCOME AFTER REVASCULARIZATION WITH EVEROLIMUS– AND SIROLIMUS–ELUTING STENTS IN PATIENTS WITH RENAL INSUFFICIENCY: FROM THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Jens Flensted Lassen

  36. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST‐segment elevation myocardial infarction: From the Western Denmark heart registry

    Article • Catheterization and Cardiovascular Interventions, February 2013, Wiley

    Professor Jens Flensted Lassen

  37. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

    Article • The Lancet, February 2013, Elsevier

    Professor Jens Flensted Lassen

  38. CRT-58 Hybrid Coronary Revascularization Combining Off-pump Left Internal Mammary Grafting And Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, February 2013, Elsevier

    Professor Jens Flensted Lassen

  39. Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the SORT OUT IV Trial)

    Article • The American Journal of Cardiology, December 2012, Elsevier

    Professor Jens Flensted Lassen

  40. Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention

    Article • EuroIntervention, December 2012, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  41. Timely and optimal treatment of patients with STEMI

    Article • Nature Reviews Cardiology, November 2012, Springer Science + Business Media

    Professor Jens Flensted Lassen

  42. Incidence of definite stent thrombosis or in‐stent restenosis after drug‐eluting stent implantation for treatment of coronary in‐stent restenosis: From Western Denmark heart registry

    Article • Catheterization and Cardiovascular Interventions, November 2012, Wiley

    Professor Jens Flensted Lassen

  43. Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry

    Article • BMC Cardiovascular Disorders, October 2012, Springer Science + Business Media

    Professor Jens Flensted Lassen

  44. TCT-297 Stent edge dissections detected by Optical Coherence Tomography, incidence, predictors and 12-month outcome

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  45. TCT-283 Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound Trial

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  46. TCT-355 Coronary Stents In Patients With Diabetes Mellitus: The Diabetes And Drug-Eluting Stent (DiabeDES IV) Randomized Angiography Trial

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  47. TCT-347 Clinical Outcome Of Biolimus-Eluting Versus Sirolimus-Eluting Coronary Stent Implantation In Patients With And Without Diabetes Mellitus: A SORT OUT V Substudy

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  48. TCT-55 Major Adverse Cardiac Events Associated With Discontinuation Of Clopidogrel Treatment Within The First Year After Coronary Stent Implantation In Western Denmark

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  49. TCT-301 Feasibility and Results of Novel Side Branch Evaluation by Reconstructed 3-Dimensional Optical Coherence Tomography. Matched Analysis of Baseline and 12-month follow-up in Native, Jailed and Opened Side Branches

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Jens Flensted Lassen

  50. 2-Year Patient-Related Versus Stent-Related Outcomes

    Article • Journal of the American College of Cardiology, September 2012, Elsevier

    Professor Jens Flensted Lassen

  51. The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

    Article • EuroIntervention, September 2012, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  52. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

    Article • EuroIntervention, August 2012, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  53. 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

    Article • JACC Cardiovascular Interventions, August 2012, Elsevier

    Professor Jens Flensted Lassen

  54. Zotarolimus‐eluting vs. sirolimus‐eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy

    Article • European Journal of Clinical Investigation, May 2012, Wiley

    Professor Jens Flensted Lassen

  55. The Nordic Experience

    Article • March 2012, Wiley

    Professor Jens Flensted Lassen

  56. Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

    Article • BMC Cardiovascular Disorders, March 2012, Springer Science + Business Media

    Professor Jens Flensted Lassen

  57. Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  58. DIMENSIONS OF SOCIOECONOMIC STATUS AND CLINICAL OUTCOME AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  59. TWO-YEAR PATIENT-RELATED VERSUS STENT-RELATED OUTCOMES FROM THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  60. DEFINITE AND PROBABLE STENT THROMBOSIS AFTER REVASCULARIZATION WITH EVEROLIMUS- AND SIROLIMUS-ELUTING STENTS. FROM THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  61. IMPACT OF LESION LENGTH ON OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS ELUTING STENTS. A SUBSTUDY OF THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  62. OUTCOMES AFTER REVASCULARIZATION WITH EVEROLIMUS AND SIROLIMUS ELUTING STENTS IN PATIENTS WITH SMALL AND LARGE CORONARY ARTERIES. A SUBSTUDY OF THE SORT OUT IV TRIAL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Jens Flensted Lassen

  63. Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy

    Article • EuroIntervention, February 2012, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  64. Earlier reperfusion in patients with ST-elevation Myocardial infarction by use of helicopter

    Article • Scandinavian Journal of Trauma Resuscitation and Emergency Medicine, January 2012, Springer Science + Business Media

    Professor Jens Flensted Lassen

  65. Comparison of Outcomes of Patients ≥80 Years of Age Having Percutaneous Coronary Intervention According to Presentation (Stable vs Unstable Angina Pectoris/Non–ST-Segment Elevation Myocardial Infarction vs ST-Segment Elevation Myocardial Infarction)

    Article • The American Journal of Cardiology, November 2011, Elsevier

    Professor Jens Flensted Lassen

  66. Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)

    Article • The American Journal of Cardiology, November 2011, Elsevier

    Professor Jens Flensted Lassen

  67. Health Care System Delay and Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Follow-up of Population-Based Medical Registry Data

    Article • Annals of Internal Medicine, September 2011, American College of Physicians

    Professor Jens Flensted Lassen

  68. Use of three-dimensional optical coherence tomography to verify correct wire position in a jailed side branch after main vessel stent implantation

    Article • EuroIntervention, August 2011, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  69. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

    Article • EuroIntervention, July 2011, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  70. Prehospital Troponin T Testing in the Diagnosis and Triage of Patients With Suspected Acute Myocardial Infarction

    Article • The American Journal of Cardiology, May 2011, Elsevier

    Professor Jens Flensted Lassen

  71. Nonsteroidal Antiinflammatory Drug Use and Cardiovascular Risks After Coronary Stent Implantation

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2011, Wiley

    Professor Jens Flensted Lassen

  72. Long-term safety and efficacy of drug-eluting stents

    Article • The Lancet, April 2011, Elsevier

    Professor Jens Flensted Lassen

  73. TROPONIN T TESTING IN THE PREHOSPITAL DIAGNOSIS AND TRIAGE OF PATIENTS WITH SUSPECTED HEART ATTACK

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Jens Flensted Lassen

  74. Quality of cardiopulmonary resuscitation in out-of-hospital cardiac arrest is hampered by interruptions in chest compressions—A nationwide prospective feasibility study

    Article • Resuscitation, March 2011, Elsevier

    Professor Jens Flensted Lassen

  75. One or two stents for coronary bifurcation lesions?

    Article • EuroIntervention, December 2010, Europa Digital & Publishing

    Professor Jens Flensted Lassen, Dr David Hildick-Smith

  76. Zotarolimus-eluting versus sirolimus-eluting coronary stent implantation

    Article • Interventional Cardiology, December 2010, OMICS Publishing Group

    Professor Jens Flensted Lassen

  77. Sirolimus-eluting versus bare-metal stent implantation in patients with ostial lesions

    Article • International Journal of Cardiology, November 2010, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  78. Quantitative coronary analysis in the Nordic Bifurcation studies

    Article • The International Journal of Cardiovascular Imaging, October 2010, Springer Science + Business Media

    Professor Jens Flensted Lassen

  79. Reply

    Article • Journal of the American College of Cardiology, August 2010, Elsevier

    Professor Jens Flensted Lassen

  80. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, August 2010, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  81. Review of Registry and Randomised Comparisons of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents in Western Denmark

    Article • European Journal of Cardiovascular Medicine, June 2010, Healthcare Bulletin

    Professor Jens Flensted Lassen

  82. Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With and Without Diabetes Mellitus in Western Denmark

    Article • The American Journal of Cardiology, June 2010, Elsevier

    Professor Jens Flensted Lassen

  83. Consensus from the 5th European Bifurcation Club meeting

    Article • EuroIntervention, May 2010, Europa Digital & Publishing

    Professor Jens Flensted Lassen, Dr David Hildick-Smith

  84. Cardiac arrest in the catheterisation laboratory: A 5-year experience of using mechanical chest compressions to facilitate PCI during prolonged resuscitation efforts

    Article • Resuscitation, April 2010, Elsevier

    Professor Jens Flensted Lassen

  85. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

    Article • EuroIntervention, April 2010, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  86. Increased Rate of Stent Thrombosis and Target Lesion Revascularization After Filter Protection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Jens Flensted Lassen

  87. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

    Article • The Lancet, March 2010, Elsevier

    Professor Jens Flensted Lassen

  88. LONG-TERM CLINICAL OUTCOME AFTER IMPLANTATION OF SIROLIMUS-ELUTING AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS - A PREDEFINED SORT OUT II SUBSTUDY

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Jens Flensted Lassen

  89. CLINICAL PRESENTATION OF IN-STENT RESTENOSIS AND ANGIOGRAPHIC CONFIRMED STENT THROMBOSIS IN PATIENTS TREATED WITH BARE METAL OR DRUG-ELUTING STENTS. FROM WESTERN DENMARK HEART REGISTRY

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Jens Flensted Lassen

  90. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

    Article • The Lancet, February 2010, Elsevier

    Professor Jens Flensted Lassen

  91. Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease

    Article • Cardiology, January 2010, Karger Publishers

    Professor Jens Flensted Lassen

  92. Prevalence and Significance of Accelerated Idioventricular Rhythm in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

    Article • The American Journal of Cardiology, December 2009, Elsevier

    Professor Jens Flensted Lassen

  93. Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial

    Article • Journal of Nuclear Cardiology, October 2009, Elsevier

    Professor Jens Flensted Lassen

  94. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention

    Article • Catheterization and Cardiovascular Interventions, August 2009, Wiley

    Professor Jens Flensted Lassen

  95. Percutaneous coronary intervention for bifurcation lesions: 2008 consensus document from the fourth meeting of the European Bifurcation Club

    Article • EuroIntervention, May 2009, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  96. Serial Intravascular Ultrasound Analysis of Peri-Stent Remodeling and Proximal and Distal Edge Effects After Sirolimus-Eluting or Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus

    Article • The American Journal of Cardiology, April 2009, Elsevier

    Professor Jens Flensted Lassen

  97. Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial††A list of participating centers and investigators appears in t...

    Article • The American Journal of Cardiology, February 2009, Elsevier

    Professor Jens Flensted Lassen

  98. 2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents

    Article • Journal of the American College of Cardiology, February 2009, Elsevier

    Professor Jens Flensted Lassen

  99. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction

    Article • Journal of Electrocardiology, January 2009, Elsevier

    Professor Jens Flensted Lassen

  100. Temporal Course of Pregnancy-Associated Plasma Protein-A in Angioplasty-Treated ST-Elevation Myocardial Infarction Patients and Potential Significance of Concomitant Heparin Administration

    Article • The American Journal of Cardiology, January 2009, Elsevier

    Professor Jens Flensted Lassen

  101. Safety in simple versus complex stenting of coronary artery bifurcation lesions. The Nordic Bifurcation Study 14-month follow-up results

    Article • EuroIntervention, August 2008, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  102. Intravascular Ultrasound Assessment of Expansion of the Sirolimus-Eluting (Cypher Select) and Paclitaxel-Eluting (Taxus Express-2) Stent in Patients With Diabetes Mellitus

    Article • The American Journal of Cardiology, July 2008, Elsevier

    Professor Jens Flensted Lassen

  103. Comparison of Stent Thrombosis, Myocardial Infarction, and Mortality Following Drug-Eluting Versus Bare-Metal Stent Coronary Intervention in Patients With Diabetes Mellitus

    Article • The American Journal of Cardiology, July 2008, Elsevier

    Professor Jens Flensted Lassen

  104. Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions

    Article • Journal of the American College of Cardiology, May 2008, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  105. Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, March 2008, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  106. Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice

    Article • JAMA, January 2008, American Medical Association (AMA)

    Professor Jens Flensted Lassen, Kari Saunamaki

  107. Classification of coronary artery bifurcation lesions and treatments: Time for a consensus!

    Article • Catheterization and Cardiovascular Interventions, November 2007, Wiley

    Professor Manuel Pan, Professor Jens Flensted Lassen

  108. Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTE...

    Article • EuroIntervention, November 2007, Europa Digital & Publishing

    Professor Jens Flensted Lassen

  109. Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions

    Article • Journal of the American College of Cardiology, July 2007, Elsevier

    Professor Jens Flensted Lassen

  110. Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent

    Article • Heart, June 2007, BMJ

    Professor Jens Flensted Lassen

  111. Does Postsystolic Motion or Shortening Predict Recovery of Myocardial Function After Primary Percutanous Coronary Intervention?

    Article • Journal of the American Society of Echocardiography, May 2007, Elsevier

    Professor Jens Flensted Lassen

  112. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)

    Article • American Heart Journal, December 2006, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  113. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial

    Article • Journal of the American College of Cardiology, January 2006, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  114. Prehospital evaluation in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention

    Article • Journal of Electrocardiology, October 2005, Elsevier

    Professor Jens Flensted Lassen

  115. When analyses are invalidated by erroneous assumptions

    Article • International Journal of Technology Assessment in Health Care, July 2005, Cambridge University Press

    Professor Jens Flensted Lassen

  116. Haemostatic Activity in Patients with Atrial Fibrillation Treated with Low-Molecular-Weight Heparin Before and After Electrical Cardioversion

    Article • Journal of Thrombosis and Thrombolysis, June 2004, Springer Science + Business Media

    Professor Jens Flensted Lassen

  117. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?

    Article • Thrombosis Research, March 2003, Elsevier

    Professor Jens Flensted Lassen

  118. Cholesterol reduction following health screening in general practice

    Article • Scandinavian Journal of Primary Health Care, January 2002, Taylor & Francis

    Professor Jens Flensted Lassen

  119. Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices

    Article • Thrombosis Research, January 2002, Elsevier

    Professor Jens Flensted Lassen

  120. Evaluation of a Simple Dosage Scheme for Transition from Phenprocoumon to Warfarin in Oral Anticoagulation

    Article • Thrombosis Research, April 2000, Elsevier

    Professor Jens Flensted Lassen

  121. Effect of Anticoagulant Therapy on the Hypercoagulable State in Patients Carrying the Factor V Arg506Gln Mutation

    Article • Thrombosis Research, November 1998, Elsevier

    Professor Jens Flensted Lassen

  122. The Arg506Gln Mutation (FV Leiden) Among a Cohort of 4188 Unselected Danish Newborns

    Article • Thrombosis Research, March 1998, Elsevier

    Professor Jens Flensted Lassen

  123. C-reactive protein in general practice - how commonly is it used and why?

    Article • Scandinavian Journal of Primary Health Care, January 1997, Taylor & Francis

    Professor Jens Flensted Lassen

  124. Research, technology assessment, and quality assurance

    Article • European Journal of General Practice, January 1996, Taylor & Francis

    Professor Jens Flensted Lassen

  125. Hallucinogenic mushroom use by Danish students: pattern of consumption

    Article • Journal of Internal Medicine, February 1993, Wiley

    Professor Jens Flensted Lassen